CA2245398E - Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention - Google Patents

Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention

Info

Publication number
CA2245398E
CA2245398E CA2245398A CA2245398A CA2245398E CA 2245398 E CA2245398 E CA 2245398E CA 2245398 A CA2245398 A CA 2245398A CA 2245398 A CA2245398 A CA 2245398A CA 2245398 E CA2245398 E CA 2245398E
Authority
CA
Canada
Prior art keywords
azithromycin
isopropanol
degree
water
monohydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2245398A
Other languages
English (en)
Other versions
CA2245398C (fr
CA2245398A1 (fr
Inventor
Khashayar Karimian
Mehrnoush Motamedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Apotex Inc
Apotex Technologies Inc
Filing date
Publication date
Application filed by Apotex Inc, Apotex Technologies Inc filed Critical Apotex Inc
Priority to CA2245398A priority Critical patent/CA2245398E/fr
Priority to US09/373,549 priority patent/US6245903B1/en
Priority to EP99306612A priority patent/EP0984020B1/fr
Priority to AT99306612T priority patent/ATE221078T1/de
Priority to DE69902212T priority patent/DE69902212T2/de
Publication of CA2245398A1 publication Critical patent/CA2245398A1/fr
Application granted granted Critical
Publication of CA2245398C publication Critical patent/CA2245398C/fr
Publication of CA2245398E publication Critical patent/CA2245398E/fr
Priority to US10/454,586 priority patent/USRE39087E1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

CA2245398A 1998-08-21 1998-08-21 Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention Expired - Lifetime CA2245398E (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CA2245398A CA2245398E (fr) 1998-08-21 Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention
US09/373,549 US6245903B1 (en) 1998-08-21 1999-08-13 Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
AT99306612T ATE221078T1 (de) 1998-08-21 1999-08-20 Azithromycinmonohydrat-isopropanol-clathrate und methoden zu deren herstellung
DE69902212T DE69902212T2 (de) 1998-08-21 1999-08-20 Azithromycinmonohydrat-Isopropanol-Clathrate und Methoden zu deren Herstellung
EP99306612A EP0984020B1 (fr) 1998-08-21 1999-08-20 Clathrates d'azithromycine monohydratée et d'isopropanol ainsi que leur méthode de fabrication
US10/454,586 USRE39087E1 (en) 1998-08-21 2003-06-05 Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2245398A CA2245398E (fr) 1998-08-21 Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention

Publications (3)

Publication Number Publication Date
CA2245398A1 CA2245398A1 (fr) 2000-02-21
CA2245398C CA2245398C (fr) 2002-01-29
CA2245398E true CA2245398E (fr) 2002-01-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP0984020B1 (fr) Clathrates d'azithromycine monohydratée et d'isopropanol ainsi que leur méthode de fabrication
RU2230748C2 (ru) Способ получения кларитромицина в виде кристаллов формы ii
US20260085065A1 (en) Crystalline form of sglt inhibitor
US4492688A (en) Antibacterial cyclic ethers of 9-deoxo-9a-aza-9a-homoerythromycin A and intermediates therefor
CA2067274C (fr) Solvates de dirithromycine et un procede pour les isoler du dirithromycine ii
SU1011051A3 (ru) Способ получени @ -гликозиловых производных антибиотиков из группы антрациклинов
CA2245398E (fr) Clathrate d'isopropanol monohydrate d'azithromycine et methodes d'obtention
NO146711B (no) Analogifremgangsmaate for fremstilling av oleandomycin- og erytromycinderivater
AU2012265238B2 (en) Crystallization of epirubicin hydrochloride
US4124755A (en) 11-Alkanoyl-4"-deoxy-4"-isonitrilo-oleandomycin derivatives
EP0087915B1 (fr) Oléandomycines et erythromycines semi-synthétiques
RU2802443C1 (ru) Промежуточное соединение, применяемое для синтеза ингибитора sglt, и способ получения ингибитора sglt с применением указанного промежуточного соединения
KR100452026B1 (ko) 6-메틸에리스로마이신 ａ의 제조방법
JPH02122000A (ja) エライオフイリンおよびエライオフイリン誘導体の塩基性開裂生成物
EP0132026B1 (fr) Ethers cycliques à activité antibactérielle, de 9-déoxy-9a-aza-9a-homoérythromycine et produits intermédiaires
KR100512776B1 (ko) 클라리스로마이신 결정형 ２형의 제조방법
MXPA04010587A (es) [2r-(2r*, 3s*, 4r*, 5r*, 8r*, 10r*, 11r*, 2s*, 3s*, 14r*)]- 13-[(2 6-d deoxi-3-c- metil- -l- ribo- hexopiranosil) oxi]-2-etil-3], 4, 10- trihidroxi-3, 5, 6, 8, 10, 12, 14-heptametil- 11-[[3, 4, 6-trideoxi- 3-(dimetilamino)- -d-xilo-5 hexopiranosil] o
CA1128506A (fr) Derives de 4"-erythromycine a semi-synthetiques
Hammann et al. Secondary metabolites by chemical screening-6 cleavage of elaiophylin and transformation into a spiroketal building block
MXPA04010586A (es) Un nuevo compuesto 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a cristalino anhidro y proceso para su fabricacion.
EA013082B1 (ru) Кристаллические формы макролидных соединений, обладающих противовоспалительной активностью
HK1131781A (en) Crystalline form i of ortataxel